Jessica Magid-Bernstein MD, PhD , Jennifer Yan BS , Alison L. Herman BA , Zili He MS , Conor W. Johnson BS , Hannah Beatty BS , Rachel Choi MS , Sofia Velazquez BA , Gracey Sorensen BS , Sithmi Jayasundara BS , Lauren Grychowski BS , Abdelaziz Amllay MD , Guido J. Falcone MD, ScD, MPH , Jennifer Kim MD, PhD , Nils Petersen MD, PhD, MSc , Lena O’Keefe MD, MS , Emily J. Gilmore MD , Charles Matouk MD , Kevin N. Sheth MD , Lauren H. Sansing MD, MS
{"title":"Early CSF inflammatory markers after aneurysmal subarachnoid hemorrhage and their relationship to disease severity and shunt placement","authors":"Jessica Magid-Bernstein MD, PhD , Jennifer Yan BS , Alison L. Herman BA , Zili He MS , Conor W. Johnson BS , Hannah Beatty BS , Rachel Choi MS , Sofia Velazquez BA , Gracey Sorensen BS , Sithmi Jayasundara BS , Lauren Grychowski BS , Abdelaziz Amllay MD , Guido J. Falcone MD, ScD, MPH , Jennifer Kim MD, PhD , Nils Petersen MD, PhD, MSc , Lena O’Keefe MD, MS , Emily J. Gilmore MD , Charles Matouk MD , Kevin N. Sheth MD , Lauren H. Sansing MD, MS","doi":"10.1016/j.jstrokecerebrovasdis.2025.108395","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The inflammatory response within the central nervous system is a key driver of secondary brain injury after aneurysmal subarachnoid hemorrhage (aSAH). Less is known about the impact that inflammation has on complications like persistent post-hemorrhagic hydrocephalus. To explore the association between inflammation, disease severity, and permanent shunt placement, we characterized the early cytokine profiles of the blood and cerebrospinal fluid (CSF) of patients with aSAH.</div></div><div><h3>Methods</h3><div>Biological samples were collected from aSAH patients admitted to a single-center Neurosciences Intensive Care Unit between 2014 and 2024. Control CSF samples were collected from patients undergoing permanent shunt placement for normal pressure hydrocephalus. A multiplex bead-based immunoassay was used to analyze a panel of cytokines in plasma and CSF samples. Clinical variables, including demographics, disease severity, and permanent shunt placement were collected.</div></div><div><h3>Results</h3><div>Plasma and/or CSF samples were collected from 83 patients (58 aSAH patients, 25 controls). In aSAH patients, C<img>C motif chemokine ligand-2 (CCL2), interleukin-6 (IL-6), granulocyte-colony stimulating factor (G-CSF), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF) were all elevated in CSF compared to plasma (<em>p</em> < 0.05 for all comparisons) and in the CSF of aSAH patients as compared to controls (<em>p</em> < 0.001 for all comparisons). However, only G-CSF and VEGF were associated with clinical severity at presentation when considering Hunt and Hess score as a dichotomized variable (<em>p</em> = 0.026 and <em>p</em> = 0.043, respectively). In multivariable models adjusted for age, sex, and modified Fisher Scale score, early CSF concentrations of IL-6 and IL-8 were associated with increased need for permanent shunt placement (<em>p</em> = 0.030 and <em>p</em> = 0.040, respectively).</div></div><div><h3>Conclusions</h3><div>Within 72 hours of aSAH, proinflammatory cytokines can be detected at higher concentrations in CSF than in plasma, and at higher concentrations in aSAH patients compared to controls. Early concentrations of certain pro-inflammatory cytokines are associated with increased likelihood of persistent post-hemorrhagic shunt dependent hydrocephalus, independent of initial disease severity. These data support preclinical models of CNS inflammation after aSAH and suggest that early innate inflammation contributes to hydrocephalus.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 9","pages":"Article 108395"},"PeriodicalIF":2.0000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305725001739","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The inflammatory response within the central nervous system is a key driver of secondary brain injury after aneurysmal subarachnoid hemorrhage (aSAH). Less is known about the impact that inflammation has on complications like persistent post-hemorrhagic hydrocephalus. To explore the association between inflammation, disease severity, and permanent shunt placement, we characterized the early cytokine profiles of the blood and cerebrospinal fluid (CSF) of patients with aSAH.
Methods
Biological samples were collected from aSAH patients admitted to a single-center Neurosciences Intensive Care Unit between 2014 and 2024. Control CSF samples were collected from patients undergoing permanent shunt placement for normal pressure hydrocephalus. A multiplex bead-based immunoassay was used to analyze a panel of cytokines in plasma and CSF samples. Clinical variables, including demographics, disease severity, and permanent shunt placement were collected.
Results
Plasma and/or CSF samples were collected from 83 patients (58 aSAH patients, 25 controls). In aSAH patients, CC motif chemokine ligand-2 (CCL2), interleukin-6 (IL-6), granulocyte-colony stimulating factor (G-CSF), interleukin-8 (IL-8), and vascular endothelial growth factor (VEGF) were all elevated in CSF compared to plasma (p < 0.05 for all comparisons) and in the CSF of aSAH patients as compared to controls (p < 0.001 for all comparisons). However, only G-CSF and VEGF were associated with clinical severity at presentation when considering Hunt and Hess score as a dichotomized variable (p = 0.026 and p = 0.043, respectively). In multivariable models adjusted for age, sex, and modified Fisher Scale score, early CSF concentrations of IL-6 and IL-8 were associated with increased need for permanent shunt placement (p = 0.030 and p = 0.040, respectively).
Conclusions
Within 72 hours of aSAH, proinflammatory cytokines can be detected at higher concentrations in CSF than in plasma, and at higher concentrations in aSAH patients compared to controls. Early concentrations of certain pro-inflammatory cytokines are associated with increased likelihood of persistent post-hemorrhagic shunt dependent hydrocephalus, independent of initial disease severity. These data support preclinical models of CNS inflammation after aSAH and suggest that early innate inflammation contributes to hydrocephalus.
期刊介绍:
The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.